Previous cell therapy studies used Cx3cr1-positive macrophages to inhibit the inflammatory response after MI to repair ischemic heart damage (9), and we found that this group of cells secreted a decrease in TGF-β1, which helped improve long-term cardiac function. This evidence concerns the gene CX3CR1 and myocardial infarction.